{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication via swap agreements",
        "Counterparty risk exposure",
        "Complex underlying index (UBS CMCI Livestock TR Index)",
        "No capital protection",
        "Issuer credit risk",
        "Exercise and maturity features with contingent redemption",
        "Potentially difficult early exit with high costs or losses"
    ],
    "classification": "complex",
    "supporting_data": "The product is an Open End Tracker Certificate (ETP) issued by UBS AG, linked to the UBS CMCI Livestock TR Index, which is a commodity index. The KIID explicitly states that the product is not simple and may be difficult to understand, indicating complexity. The product does not grant ownership rights to the underlying assets and relies on a predefined exercise procedure to redeem the product, which is typical for synthetic replication structures. The presence of a multiplier and management fee adjustments, along with the issuer's right to exercise and redeem, indicate embedded derivative features. The product exposes investors to issuer credit risk and counterparty risk, as it is a debt instrument without deposit protection. The risk indicator is medium (4/7), but the product carries significant complexity due to its structure, including the use of swaps or similar derivative instruments to replicate the index performance. The underlying index is a commodity index with potential roll costs and contango/backwardation effects, adding to complexity. The product is not UCITS compliant, further supporting the complex classification. The PRIIPs KID and factsheet confirm the use of synthetic replication and derivative instruments, with no physical replication of underlying commodities. Early redemption is difficult and costly, increasing risk and complexity. These factors combined meet MiFID II criteria for a complex financial instrument."
}